Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Anthra[1,9-cd]pyrazol-6(2H)-one | 129-56-6 | 99.7% | 200 MG
SDP

Supplier:  Medchemexpress LLC HY12041200MG

Encompass_Preferred

SP600125 is a reversible, ATP-competitive inhibitor of c-Jun N-terminal kinases (JNK1, JNK2, JNK3) used as a research reagent. Reported IC50 values are 40 nM for JNK1, 40 nM for JNK2, and 90 nM for JNK3. The compound has also been reported to inhibit ferroptosis and to induce conversion from autophagy to apoptosis in certain cancer cells.

  • ATP-competitive inhibitor of JNK1, JNK2, and JNK3.
  • IC50 values: 40 nM (JNK1), 40 nM (JNK2), 90 nM (JNK3).
  • High purity (99.73%).
  • Available as a 200 MG pack for research and analytical use.
  • Storage: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (2 years) or -20°C (1 year).
  • Intended for research use only.

Catalog No. 50-002-33193


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.